National Institutes of Health
Cancer Trial Using Monoclonal Antibody Finds Remission in Every Patient: Report
A cancer trial has reportedly become the first in the world to completely remove the disease in every patient, according to a study published Sunday in the New England Journal of Medicine. The study, titled “PD-1 Blockade in Mismatch Repair—Deficient, Locally Advanced Rectal Cancer” was conducted among 12 rectal cancer patients, all of which had a […]
NIH Wipes Detailed Explanation of Gain of Function Research From Website
The National Institutes of Health has made a change to its website. They wiped a detailed explanation of gain of function research. Why now?—as lawmakers accuse the agency of lying to Congress about this research.
NTD Evening News Full Broadcast (Oct. 5)
A Facebook whistleblower testifies before the Senate, the director of the National Institutes of Health will step down by the end of the year, and the Department of Justice launches an effort with the FBI to combat threats parents have directed toward school board members.
US Grant to Wuhan Lab to Enhance Bat-Based Coronaviruses Was Never Scrutinized by HHS Review Board: NIH
An oversight board created to scrutinize research that would enhance highly dangerous pathogens did not review a National Institutes of Health grant that funded a lab in Wuhan, China, to genetically modify bat-based coronaviruses. Experts say the NIH grant describes scientists conducting gain-of-function research, a risky area of study that, in this case, made SARS-like […]
US Nonprofit With Ties to Wuhan Lab Violated Federal Law by Failing to Disclose Taxpayer Funding, Complaint Alleges
A U.S. nonprofit with close ties to the Wuhan Institute of Virology violated federal law by failing to disclose that taxpayer funds supported its work, according to a complaint a taxpayer watchdog group filed on Monday. EcoHealth Alliance (EHA) diverted $600,000 in taxpayer funds to the WIV in the form of National Institutes of Health […]
NIH Trial: Gilead’s Drug Works Best in COVID Patients on Oxygen
The U.S. National Institutes of Health (NIH) on Friday said that data from its trial of Gilead Sciences Inc’s remdesivir show that the drug offers the most benefit for COVID-19 patients who need extra oxygen but do not require mechanical ventilation. The peer-reviewed data was published in the New England Journal of Medicine. The trial, […]